TDR Targets

Basic information

Technical information

TDR Targets ID: 26573
Name: dodecyl N-[[2,6-di(propan-2-yl)phenyl]carbamo yl]sulfamate
MW: 468.693 | Formula: C25H44N2O4S
H donors: 2 H acceptors: 3 LogP: 8.93 Rotable bonds: 18
Rule of 5 violations (Lipinski): 1
SMILES: CCCCCCCCCCCCOS(=O)(=O)NC(=O)Nc1c(cccc1C(C)C)C(C)C
InChi: 1S/C25H44N2O4S/c1-6-7-8-9-10-11-12-13-14-15-19-31-32(29,30)27-25(28)26-24-22(20(2)3)17-16-18-23(24)21(4)5/h16-18,20-21H,6-15,19H2,1-5H3,(H2,26,27,28)
InChiKey: AACIOBUVHVAPJZ-UHFFFAOYSA-N

Network

Hover on a compound node to display the structore

Target Layer

Model Organisms

Species	Viewmode
Arabidopsis thaliana
Caenorhabditis elegans
Dictyostelium discoideum
Drosophila melanogaster
Escherichia coli
Homo sapiens
Mus musculus
Oryza sativa
Saccharomyces cerevisiae
Schmidtea mediterranea
Other organisms

TDR Pathogens:

Species	Viewmode
Brugia malayi
Chlamydia trachomatis
Echinococcus granulosus
Entamoeba histolytica
Echinococcus multilocularis
Giardia lamblia
Leishmania major
Loa Loa (eye worm)
Mycobacterium leprae
Mycobacterium tuberculosis
Mycobacterium ulcerans
Onchocerca volvulus
Plasmodium falciparum
Plasmodium vivax
Schistosoma mansoni
Trypanosoma brucei
Trypanosoma cruzi
Toxoplasma gondii
Treponema pallidum
Trichomonas vaginalis
Wolbachia endosymbiont of Brugia malayi

Other Pathogens:

Species	Viewmode
Babesia bovis
Candida albicans
Cryptosporidium hominis
Cryptosporidium parvum
Leishmania braziliensis
Leishmania donovani
Leishmania infantum
Leishmania mexicana
Neospora caninum
Plasmodium berghei
Plasmodium knowlesi
Plasmodium yoelii
Schistosoma japonicum
Trypanosoma brucei gambiense
Trypanosoma congolense
Theileria parva

Compound Layer

This is a work in progress. Come back soon to try this features!

Clustering layers

This is a work in progress. Come back soon to try this features!

Synonyms

dodecyl N-[(2,6-diisopropylphenyl)carbamoyl]sulfamate
N-[(2,6-diisopropylanilino)-oxomethyl]sulfamic acid dodecyl ester
N-[(2,6-diisopropylphenyl)carbamoyl]sulfamic acid lauryl ester
N-[[(2,6-diisopropylphenyl)amino]-oxomethyl]sulfamic acid dodecyl ester

Targets

Known targets for this compound

Species	Target name	Source	Bibliographic reference
Rattus norvegicus	Acyl coenzyme A:cholesterol acyltransferase 1	Starlite/ChEMBL	References

Predicted pathogen targets for this compound

By orthology

Species	Potential target	Known druggable target/s	Ortholog Group
Loa Loa (eye worm)	hypothetical protein	Get druggable targets OG5_133487	All targets in OG5_133487
Echinococcus granulosus	sterol O acyltransferase 1	Get druggable targets OG5_133487	All targets in OG5_133487
Loa Loa (eye worm)	hypothetical protein	Get druggable targets OG5_133487	All targets in OG5_133487
Schistosoma mansoni	sterol O-acyltransferase 1	Get druggable targets OG5_133487	All targets in OG5_133487
Schistosoma japonicum	ko:K00637 sterol O-acyltransferase [EC2.3.1.26], putative	Get druggable targets OG5_133487	All targets in OG5_133487
Echinococcus multilocularis	sterol O acyltransferase 1	Get druggable targets OG5_133487	All targets in OG5_133487

By sequence similarity to non orthologous known druggable targets

Species	Potential target	Known druggable target	Length	Alignment span	Identity
Toxoplasma gondii	acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha	Acyl coenzyme A:cholesterol acyltransferase 1	545 aa	510 aa	24.1 %
Neospora caninum	sterol O-acyltransferase, putative	Acyl coenzyme A:cholesterol acyltransferase 1	545 aa	510 aa	21.2 %
Dictyostelium discoideum	diacylglycerol O-acyltransferase 1	Acyl coenzyme A:cholesterol acyltransferase 1	545 aa	547 aa	22.3 %

Ranking Plot

Putative Targets List

Species	Potential target	Raw	Global	Species
Mycobacterium leprae	conserved hypothetical protein	0.0105	0.0761	0.0655
Plasmodium falciparum	GAF domain-related protein, putative	0.0105	0.0761	0.4644
Loa Loa (eye worm)	N-myristoyltransferase 2	0.0179	0.1638	0.6195
Echinococcus granulosus	glycylpeptide N tetradecanoyltransferase	0.0179	0.1638	0.2599
Trypanosoma brucei	N-myristoyltransferase	0.0179	0.1638	0.4803
Echinococcus multilocularis	p2X purinoceptor 4	0.0573	0.6303	1
Trichomonas vaginalis	cGMP-dependent 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	conserved hypothetical protein	0.0288	0.2932	0.8598
Brugia malayi	pyridoxamine 5'-phosphate oxidase	0.0088	0.0559	0.3412
Schistosoma mansoni	sterol O-acyltransferase 1	0.0264	0.2644	0.4196
Trichomonas vaginalis	cAMP-specific phosphodiesterase, putative	0.0329	0.341	1
Echinococcus multilocularis	sterol O acyltransferase 1	0.0264	0.2644	0.4196
Plasmodium falciparum	glycylpeptide N-tetradecanoyltransferase	0.0179	0.1638	1
Toxoplasma gondii	hypothetical protein	0.0288	0.2932	1
Trichomonas vaginalis	conserved hypothetical protein	0.0105	0.0761	0.2231
Trypanosoma cruzi	N-myristoyl transferase, putative	0.0179	0.1638	0.4803
Mycobacterium ulcerans	naphthoate synthase	0.0885	1	1
Trichomonas vaginalis	high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0145	0.1239	0.3632
Mycobacterium tuberculosis	Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase)	0.0885	1	1
Schistosoma mansoni	cgmp-dependent 35-cyclic phosphodiesterase	0.0145	0.1239	0.1965
Mycobacterium ulcerans	putative regulatory protein	0.0105	0.0761	0.0214
Brugia malayi	Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative	0.0145	0.1239	0.7562
Trichomonas vaginalis	cGMP-dependent 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Echinococcus granulosus	sterol O acyltransferase 1	0.0264	0.2644	0.4196
Trichomonas vaginalis	cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Plasmodium vivax	glycylpeptide N-tetradecanoyltransferase, putative	0.0179	0.1638	1
Schistosoma mansoni	N-myristoyltransferase	0.0179	0.1638	0.2599
Trichomonas vaginalis	cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Trypanosoma brucei	cAMP-specific phosphodiesterase	0.0329	0.341	1
Trichomonas vaginalis	cAMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Loa Loa (eye worm)	hypothetical protein	0.0145	0.1239	0.4685
Trichomonas vaginalis	cAMP-specific phosphodiesterase, putative	0.0224	0.2172	0.6368
Echinococcus granulosus	p2X purinoceptor 4	0.0573	0.6303	1
Trichomonas vaginalis	high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	N-myristoyl transferase, putative	0.0117	0.0912	0.2675
Trichomonas vaginalis	cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	cAMP and cAMP-inhibited cGMP 3,5-cyclic phosphodiesterase, putative	0.0224	0.2172	0.6368
Trypanosoma cruzi	cAMP specific phosphodiesterase, putative	0.0329	0.341	1
Echinococcus granulosus	pyridoxine 5' phosphate oxidase	0.0076	0.0426	0.0676
Mycobacterium tuberculosis	Two component sensor histidine kinase DosT	0.0105	0.0761	0.0214
Echinococcus granulosus	p2X purinoceptor 4	0.0573	0.6303	1
Trichomonas vaginalis	calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Mycobacterium ulcerans	two component sensor histidine kinase DevS	0.0105	0.0761	0.0214
Trichomonas vaginalis	high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	cGMP-inhibited 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Schistosoma mansoni	P2X receptor subunit	0.0573	0.6303	1
Brugia malayi	N-myristoyltransferase 2	0.0179	0.1638	1
Trypanosoma cruzi	N-myristoyl transferase, putative	0.0179	0.1638	0.4803
Trichomonas vaginalis	cAMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Loa Loa (eye worm)	hypothetical protein	0.0264	0.2644	1
Trypanosoma cruzi	cAMP specific phosphodiesterase, putative	0.0329	0.341	1
Echinococcus multilocularis	p2X purinoceptor 4	0.0573	0.6303	1
Leishmania major	N-myristoyl transferase, putative	0.0179	0.1638	0.4803
Loa Loa (eye worm)	hypothetical protein	0.0049	0.0101	0.0382
Toxoplasma gondii	hypothetical protein	0.0105	0.0761	0.2594
Echinococcus granulosus	dual 3'5' cyclic AMP and GMP phosphodiesterase	0.0329	0.341	0.5411
Trichomonas vaginalis	cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Mycobacterium tuberculosis	Two component sensor histidine kinase DevS	0.0105	0.0761	0.0214
Echinococcus granulosus	cAMP and cAMP inhibited cGMP 3'5' cyclic	0.0145	0.1239	0.1965
Plasmodium vivax	hypothetical protein, conserved	0.0105	0.0761	0.4644
Trichomonas vaginalis	calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Loa Loa (eye worm)	hypothetical protein	0.0238	0.2339	0.8847
Trichomonas vaginalis	cAMP/cGMP cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Schistosoma mansoni	P2X receptor subunit	0.0438	0.471	0.7474
Trichomonas vaginalis	high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Echinococcus multilocularis	cAMP and cAMP inhibited cGMP 3',5' cyclic	0.0145	0.1239	0.1965
Echinococcus multilocularis	glycylpeptide N tetradecanoyltransferase	0.0179	0.1638	0.2599
Trypanosoma cruzi	cAMP specific phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	conserved hypothetical protein	0.0329	0.341	1
Schistosoma mansoni	P2X receptor subunit	0.0573	0.6303	1
Trichomonas vaginalis	rod cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	rod cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Entamoeba histolytica	glycylpeptide N-tetradecanoyltransferase, putative	0.0179	0.1638	0.5
Trichomonas vaginalis	cone cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	cone cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative	0.0145	0.1239	0.3632
Trypanosoma brucei	cAMP-specific phosphodiesterase	0.0329	0.341	1
Schistosoma mansoni	pyridoxamine 5'-phosphate oxidase	0.0088	0.0559	0.0887
Echinococcus multilocularis	p2X purinoceptor 4	0.0573	0.6303	1
Toxoplasma gondii	hypothetical protein	0.0105	0.0761	0.2594
Trichomonas vaginalis	N-myristoyl transferase, putative	0.0179	0.1638	0.4803
Mycobacterium ulcerans	putative regulatory protein	0.0105	0.0761	0.0214
Trichomonas vaginalis	cAMP-specific phosphodiesterase, putative	0.0329	0.341	1
Schistosoma mansoni	camp/cgmp cyclic nucleotide phosphodiesterase	0.0329	0.341	0.5411
Trichomonas vaginalis	conserved hypothetical protein	0.0288	0.2932	0.8598
Echinococcus multilocularis	dual 3',5' cyclic AMP and GMP phosphodiesterase	0.0329	0.341	0.5411
Trichomonas vaginalis	cGMP-dependent 3,5-cyclic phosphodiesterase, putative	0.0145	0.1239	0.3632
Echinococcus multilocularis	pyridoxine 5' phosphate oxidase	0.0088	0.0559	0.0887
Loa Loa (eye worm)	pyridoxamine 5'-phosphate oxidase	0.0049	0.0101	0.0382
Loa Loa (eye worm)	hypothetical protein	0.0105	0.0761	0.2877
Brugia malayi	3'5'-cyclic nucleotide phosphodiesterase family protein	0.0145	0.1239	0.7562
Trichomonas vaginalis	calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Loa Loa (eye worm)	pyridoxamine 5'-phosphate oxidase	0.0049	0.0101	0.0382
Trichomonas vaginalis	calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative	0.0329	0.341	1
Trichomonas vaginalis	conserved hypothetical protein	0.0288	0.2932	0.8598
Echinococcus granulosus	p2X purinoceptor 4	0.0573	0.6303	1
Toxoplasma gondii	GAF domain-containing protein	0.0105	0.0761	0.2594
Trypanosoma cruzi	cAMP specific phosphodiesterase, putative	0.0224	0.2172	0.6368
Giardia lamblia	CDC72	0.0179	0.1638	1
Schistosoma mansoni	P2X receptor subunit	0.0438	0.471	0.7474
Trypanosoma brucei	N-myristoyl transferase, putative	0.0179	0.1638	0.4803
Trichomonas vaginalis	rod cGMP-specific 3,5-cyclic phosphodiesterase, putative	0.0329	0.341	1

Activities

Activity type	Activity value	Assay description	Source	Reference
Delta HDL (functional)	= 67 %	Chronic in vivo activity of the compound was measured by the concentration of high density lipoproteins (HDL) in cholesterol fed rats	ChEMBL.	8632431
Delta HDL (functional)	= 67 %	Chronic in vivo activity of the compound was measured by the concentration of high density lipoproteins (HDL) in cholesterol fed rats	ChEMBL.	8632431
Delta TC (functional)	= -75 %	Acute in vivo activity measured by total plasma cholesterol concentration levels (TC) at 30 mg/kg dose	ChEMBL.	8632431
Delta TC (functional)	= -53 %	Acute in vivo activity of the compound was measured by the total plasma cholesterol concentration levels(TC) at dose 3 mg/kg	ChEMBL.	8632431
Delta TC (functional)	= -53 %	Acute in vivo activity of the compound was measured by the total plasma cholesterol concentration levels(TC) at dose 3 mg/kg	ChEMBL.	8632431
Delta TC (functional)	= -52 %	Chronic in vivo activity of the compound was measured by the total cholesterol concentration levels in cholesterol fed rats	ChEMBL.	8632431
Delta TC (functional)	= -52 %	Chronic in vivo activity of the compound was measured by the total cholesterol concentration levels in cholesterol fed rats	ChEMBL.	8632431
IC50 (binding)	= 6.8 uM	In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase 1 in microsomes of rat liver	ChEMBL.	8632431
IC50 (binding)	= 6.8 uM	In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase 1 in microsomes of rat liver	ChEMBL.	8632431

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

ChEMBL: CHEMBL22985
PubChem: 10648781

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.

Detailed information for compound 26573